These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2502236)

  • 1. Tetrahydroaminoacridine in Alzheimer's disease.
    Scott PV; de Jong M
    BMJ; 1989 May; 298(6682):1250-1. PubMed ID: 2502236
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute hepatitis after tetrahydroaminoacridine administration for Alzheimer's disease.
    Hammel P; Larrey D; Bernuau J; Kalafat M; Fréneaux E; Babany G; Degott C; Feldmann G; Pessayre D; Benhamou JP
    J Clin Gastroenterol; 1990 Jun; 12(3):329-31. PubMed ID: 2362104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity of tetrahydroaminoacridine.
    Ames DJ; Bhathal PS; Davies BM; Fraser JR
    Lancet; 1988 Apr; 1(8590):887. PubMed ID: 2895395
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinergic side-effects of tetrahydroaminoacridine.
    Levy R
    Lancet; 1988 Dec; 2(8625):1421. PubMed ID: 2904542
    [No Abstract]   [Full Text] [Related]  

  • 5. Alzheimer's drug trial put on hold.
    Marx JL
    Science; 1987 Nov; 238(4830):1041-2. PubMed ID: 3317822
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydroaminoacridine (THA) in Alzheimer's disease.
    Byrne J; Arie T
    BMJ; 1989 Apr; 298(6677):845-6. PubMed ID: 2497817
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholinergic side-effects of tetrahydroaminoacridine.
    Wilcock GK; Surmon D; Forsyth D; Morgan R
    Lancet; 1988 Dec; 2(8623):1305. PubMed ID: 2904022
    [No Abstract]   [Full Text] [Related]  

  • 9. Heterogeneity of adverse hepatic reactions to tetrahydroaminoacridine.
    Ames DJ; Bhathal PS; Davies BM; Fraser JR; Gibson PR; Roberts S
    Aust N Z J Med; 1990 Apr; 20(2):193-5. PubMed ID: 2344330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory arrest following bupivicaine retrobulbar block.
    Hathaway EG
    Ann Ophthalmol; 1983 Dec; 15(12):1175. PubMed ID: 6660699
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies.
    Summers WK; Tachiki KH; Kling A
    Eur Neurol; 1989; 29 Suppl 3():28-32. PubMed ID: 2693104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydroaminoacridine in Alzheimer's disease.
    Walsh AC
    BMJ; 1989 Jun; 298(6687):1579. PubMed ID: 2503129
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study.
    Forsyth DR; Surmon DJ; Morgan RA; Wilcock GK
    Age Ageing; 1989 Jul; 18(4):223-9. PubMed ID: 2683619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrahydroaminoacridine and Alzheimer's disease.
    Lancet; 1987 Feb; 1(8530):444-5. PubMed ID: 2880235
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrine and lecithin in Alzheimer's disease.
    BMJ; 1990 Apr; 300(6729):939-40. PubMed ID: 2337722
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type.
    N Engl J Med; 1987 Jun; 316(25):1603-5. PubMed ID: 3587295
    [No Abstract]   [Full Text] [Related]  

  • 17. Tetrahydroaminoacridine and Alzheimer's disease.
    Levy R
    Lancet; 1987 Feb; 1(8528):322. PubMed ID: 2880126
    [No Abstract]   [Full Text] [Related]  

  • 18. Tetrahydroaminoacridine and lecithin for Alzheimer's disease.
    N Engl J Med; 1990 Sep; 323(13):919-20. PubMed ID: 2395447
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?].
    Drukarch B; Stoof JC
    Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1833-5. PubMed ID: 3185771
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term hepatotoxicity of tacrine.
    Summers WK; Koehler AL; Marsh GM; Tachiki K; Kling A
    Lancet; 1989 Apr; 1(8640):729. PubMed ID: 2564541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.